Rainier van Roessel re-elected Chairman of the Supervisory Board of LANXESS AG

Uta Kemmerich-Keil replaces Heike Hanagarth on the Supervisory Board

Cologne, May 21, 2026 – The Supervisory Board of LANXESS AG today re-elected Dr. Rainier van Roessel (68) as Chairman of the Supervisory Board at its inaugural meeting. The Annual Stockholders’ Meeting had previously confirmed him as a member of the Supervisory Board for another four years. Dr. van Roessel, who holds a doctorate in business administration, has served as Chairman of the Supervisory Board of the specialty chemicals company since May 2024, having joined the board in 2022.

Dr. Rainier van Roessel began his professional career at Bayer AG and has worked for LANXESS AG since its founding in 2004, serving as Labor Director and a member of the Executive Board since 2007. He stepped down from the LANXESS Executive Board at the end of 2019.

Ms. Uta Kemmerich-Keil (59) joins the Supervisory Board of LANXESS AG as a new member. She was also elected by the shareholders at today’s Annual Stockholders’ Meeting. The graduate in economics most recently headed the International Personal Healthcare business at Procter & Gamble. She has extensive experience in various operational management roles at large, internationally active corporations in the healthcare and consumer goods industries. Kemmerich-Keil succeeds Dr. Heike Hanagarth, who has served as a member of the Supervisory Board of LANXESS AG on the shareholder representatives’ side since 2016. Dr. Hanagarth did not stand for re-election.


Information for editors:
All LANXESS news releases and their accompanying photos can be found at http://press.lanxess.com. Recent photos of the Board of Management and other LANXESS image material are available at http://photos.lanxess.com.

You can find further information concerning LANXESS chemistry at http://lanxess.com/en/Media/Stories.

MORE ABOUT THIS TOPIC

INVESTOR NEWS

LANXESS confirms guidance despite subdued start to the year

May 07, 2026
INVESTOR NEWS

LANXESS once again leads the European Dow Jones Best-in-Class Index

May 01, 2026
INVESTOR NEWS

LANXESS expects business to pick up in the second half of 2026 at the earliest

March 19, 2026
INVESTOR NEWS

LANXESS: Moody’s rating change with limited impact on financing costs

March 09, 2026
INVESTOR NEWS

LANXESS: Update on ENVALIOR Stake

March 05, 2026